Pancreatic Neoplasms: all 3,311 studies
Page 18 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer PatientsStatus unknownNCT05138302
- A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine RegimenStatus unknownNCT05138159Phase 2
- The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
- EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.TerminatedNCT05131776Phase 2/3
- HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsTerminatedNCT05124743
- CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without PanitumumabActive, not recruitingNCT05121038Phase 1/2
- Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.TerminatedNCT05116917Phase 2
- MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDACTerminatedNCT05114213Phase 2
- Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to SurgeryCompletedNCT05111353Phase 1
- Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open PancreatoduodenectomyCompletedNCT05110573
- Second Opinions in OncologyCompletedNCT05102500
- 25G and 22G Puncture NeedlesStatus unknownNCT05101772
- A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic CancerStatus unknownNCT05100329Phase 2
- EUS Shear Wave for Solid Pancreatic Lesions.Status unknownNCT05095831
- Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic CancerCompletedNCT05086250Early Phase 1
- Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic CancerActive, not recruitingNCT05083780Phase 1
- Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic CancerCompletedNCT05074589Phase 3
- Pilot Study of Pancreatic Cancer ScreeningTerminatedNCT05058846
- huCART-meso + VCN-01 in Pancreatic and Ovarian CancerActive, not recruitingNCT05057715Phase 1
- A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursActive, not recruitingNCT05057013Phase 1/2
- A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic CancerActive, not recruitingNCT05055323Phase 1
- Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaStatus unknownNCT05047991Phase 2
- Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)CompletedNCT05044065Not applicable
- Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced CancersWithdrawnNCT05043987Phase 1
- Stereotactic PAncreatic RadioTherapy Adjuvant TherapyActive, not recruitingNCT05043857Not applicable
- Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic CancerStatus unknownNCT05043532Not applicable
- Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
- A Study of ERAS-007 in Patients With Advanced Gastrointestinal MalignanciesCompletedNCT05039177Phase 1/2
- Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
- Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic CancerCompletedNCT05034627Phase 1
- A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic CancerActive, not recruitingNCT05026905Phase 2
- The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic AdenocarcinomaCompletedNCT05025371
- Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic CancerActive, not recruitingNCT05013216Phase 1
- SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI)CompletedNCT05012540
- Pancreatic Cancer and Oral MicrobiomeStatus unknownNCT04993846
- Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal IrinotecanCompletedNCT04984174
- Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic CancerCompletedNCT04977596
- Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass LesionsCompletedNCT04975620Not applicable
- Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus BiosimilarsCompletedNCT04971304
- Clinical Study of LY011 in the Treatment of Advanced Pancreatic CancerStatus unknownNCT04966143Early Phase 1
- Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)Active, not recruitingNCT04956640Phase 1/2
- Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic CancerCompletedNCT04953962Phase 2
- Circulating Epigenetics in Pancreatic SurgeryStatus unknownNCT04947696
- Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic CancerActive, not recruitingNCT04940286Phase 2
- Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.CompletedNCT04937322
- Organoid-Guided Adjuvant Chemotherapy for Pancreatic CancerCompletedNCT04931394Phase 3
- High Dose Omeprazole in Patients With Pancreatic CancerTerminatedNCT04930991Early Phase 1
- A Trial of SHR-A1904 in Patients With Advanced Pancreatic CancerStatus unknownNCT04928625Phase 1
- Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic CancerActive, not recruitingNCT04927780Phase 3
- TAS-102 in Patients With Advanced, Refractory Pancreatic AdenocarcinomaCompletedNCT04923529Phase 2
- Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal SurgeryCompletedNCT04920019Not applicable
- A Prospective Randomized Multi-center Study for Efficacy of Metallic Biliary Stent Compared to Plastic Stent in Patients Receiving Neoadjuvant Chemotherapy for Resectable Pancreatic CancerStatus unknownNCT04911647Not applicable
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsCompletedNCT04902872Phase 1/2
- The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic CancerActive, not recruitingNCT04902352Not applicable
- Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic CancerStatus unknownNCT04902261Phase 2
- Intraoperative Endoscopic Ultrasound for Pancreatic CancerCompletedNCT04899739Not applicable
- Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic CancerStatus unknownNCT04897854Phase 3
- Pancreatic Surgery in Elderly PatientsCompletedNCT04893408
- NCI SBIR Contract for Patient Navigation Tool Prototype DevelopmentStatus unknownNCT04892927
- LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)CompletedNCT04889404
- Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer PatientsActive, not recruitingNCT04888312Phase 1/2
- Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic CancerActive, not recruitingNCT04887805Phase 2
- Study of a New Technique for Imaging Pancreatic CancerCompletedNCT04883775Phase 1
- PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic CancerActive, not recruitingNCT04883450
- Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic LesionsStatus unknownNCT04877340Not applicable
- Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic CancerWithdrawnNCT04870034Early Phase 1
- Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT04862260Early Phase 1
- Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal MetastasisActive, not recruitingNCT04858009Phase 2
- PanDox: Targeted Doxorubicin in Pancreatic TumoursWithdrawnNCT04852367Phase 1
- Evaluation of Endoscopic Ultrasound Shear Wave Elastography (EUS-SWE) for the Diagnosis of Pancreatic Adenocarcinoma.CompletedNCT04851106
- Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic LesionsStatus unknownNCT04843956Not applicable
- Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) PatientsTerminatedNCT04843306Not applicable
- An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) AdenocarcinomaActive, not recruitingNCT04837833Not applicable
- Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength StudyActive, not recruitingNCT04837118Not applicable
- Electroporation Potentiated Immunotherapy in CancerActive, not recruitingNCT04835402Phase 2
- To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic UltrasoundCompletedNCT04834505
- Pilot Study of 89-Zr Panitumumab in Pancreas CancerWithdrawnNCT04833959Phase 1
- DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)CompletedNCT04825834
- Sonoporation and Chemotherapy for the Treatment of Pancreatic CancerActive, not recruitingNCT04821284Phase 1/2
- Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic CancerStatus unknownNCT04814485Phase 2
- Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic AdenocarcinomaStatus unknownNCT04812808Not applicable
- EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With MalignancyStatus unknownNCT04809935Phase 4
- Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT04809766Phase 1
- Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic CancerStatus unknownNCT04808687Phase 2
- Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer MetastasisTerminatedNCT04807972Phase 1
- Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic CancerStatus unknownNCT04803851Phase 1/2
- Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerWithdrawnNCT04799431Phase 1
- A Study of Irinotecan Liposome in Advanced Pancreatic CancerCompletedNCT04796948Phase 1
- Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using SeribantumabCompletedNCT04790695Phase 2
- Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapYCompletedNCT04789980
- Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic TumorsStatus unknownNCT04783844
- Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic PancreaticoduodenectomyStatus unknownNCT04783831
- Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
- Perioperative Immune Function and Clinical Complications in PancreaduodenectomyCompletedNCT04774198
- Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)CompletedNCT04769414Phase 2
- Effects of Chewing Gum Against Postoperative IleusStatus unknownNCT04768660Not applicable
- Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid TumorsStatus unknownNCT04764084Phase 1
- The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary ZoneCompletedNCT04763642Not applicable
- National Survey and Case-vignette Study of Clinical Decisions in Pancreatic CancerCompletedNCT04755036
- Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.Active, not recruitingNCT04753879Phase 2